Literature DB >> 23530018

Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Robert L Myette1, Gwenaëlle Conseil, Sean P Ebert, Bryan Wetzel, Michael R Detty, Susan P C Cole.   

Abstract

Multidrug resistance proteins (MRPs) mediate the ATP-dependent efflux of structurally diverse compounds, including anticancer drugs and physiologic organic anions. Five classes of chalcogenopyrylium dyes (CGPs) were examined for their ability to modulate transport of [(3)H]estradiol glucuronide (E(2)17βG; a prototypical MRP substrate) into MRP-enriched inside-out membrane vesicles. Additionally, some CGPs were tested in intact transfected cells using a calcein efflux assay. Sixteen of 34 CGPs inhibited MRP1-mediated E(2)17βG uptake by >50% (IC50 values: 0.7-7.6 µM). Of 9 CGPs with IC50 values ≤2 µM, two belonged to class I, two to class III, and five to class V. When tested in the intact cells, only 4 of 16 CGPs (at 10 µM) inhibited MRP1-mediated calcein efflux by >50% (III-1, V-3, V-4, V-6), whereas a fifth (I-5) inhibited efflux by just 23%. These five CGPs also inhibited [(3)H]E(2)17βG uptake by MRP4. In contrast, their effects on MRP2 varied, with two (V-4, V-6) inhibiting E(2)17βG transport (IC(50) values: 2.0 and 9.2 µM) and two (V-3, III-1) stimulating transport (>2-fold), whereas CGP I-5 had no effect. Strikingly, although V-3 and V-4 had opposite effects on MRP2 activity, they are structurally identical except for their chalcogen atom (Se versus Te). This study is the first to identify class V CGPs, with their distinctive methine or trimethine linkage between two disubstituted pyrylium moieties, as a particularly potent class of MRP modulators, and to show that, within this core structure, differences in the electronegativity associated with a chalcogen atom can be the sole determinant of whether a compound will stimulate or inhibit MRP2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530018      PMCID: PMC3657094          DOI: 10.1124/dmd.112.050831

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  51 in total

1.  A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene.

Authors:  F Narasaki; M Oka; M Fukuda; R Nakano; K Ikeda; H Takatani; K Terashi; H Soda; O Yano; T Nakamura; L A Doyle; T Tsuruo; S Kohno
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

2.  Design and synthesis of new templates derived from pyrrolopyrimidine as selective multidrug-resistance-associated protein inhibitors in multidrug resistance.

Authors:  Shouming Wang; Nan Chi Wan; John Harrison; Warren Miller; Irina Chuckowree; Sukhjit Sohal; Timothy C Hancox; Stewart Baker; Adrian Folkes; Francis Wilson; Deanne Thompson; Simon Cocks; Hayley Farmer; Anthony Boyce; Caroline Freathy; Jan Broadbridge; John Scott; Paul Depledge; Richard Faint; Prakash Mistry; Peter Charlton
Journal:  J Med Chem       Date:  2004-03-11       Impact factor: 7.446

3.  GSH-dependent photolabeling of multidrug resistance protein MRP1 (ABCC1) by [125I]LY475776. Evidence of a major binding site in the COOH-proximal membrane spanning domain.

Authors:  Qingcheng Mao; Wei Qiu; Kevin E Weigl; Peter A Lander; Linda B Tabas; Robert L Shepard; Anne H Dantzig; Roger G Deeley; Susan P C Cole
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

Review 4.  Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.

Authors:  Ahcène Boumendjel; Hélène Baubichon-Cortay; Doriane Trompier; Thomas Perrotton; Attilio Di Pietro
Journal:  Med Res Rev       Date:  2005-07       Impact factor: 12.944

Review 5.  Mammalian multidrug-resistance proteins (MRPs).

Authors:  Andrew J Slot; Steven V Molinski; Susan P C Cole
Journal:  Essays Biochem       Date:  2011-09-07       Impact factor: 8.000

6.  Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.

Authors:  Z S Chen; S Aoki; M Komatsu; K Ueda; T Sumizawa; T Furukawa; H Okumura; X Q Ren; M G Belinsky; K Lee; G D Kruh; M Kobayashi; S Akiyama
Journal:  Int J Cancer       Date:  2001-07-01       Impact factor: 7.396

Review 7.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.

Authors:  Frans G M Russel; Jan B Koenderink; Rosalinde Masereeuw
Journal:  Trends Pharmacol Sci       Date:  2008-03-18       Impact factor: 14.819

8.  Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function.

Authors:  Isabelle J Létourneau; Andrew J Slot; Roger G Deeley; Susan P C Cole
Journal:  Drug Metab Dispos       Date:  2007-05-09       Impact factor: 3.922

9.  Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.

Authors:  Geri A Sawada; Thomas J Raub; J William Higgins; Nancy K Brennan; Teiah M Moore; Gregory Tombline; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2008-09-30       Impact factor: 3.641

10.  Photosensitization of human glioma cells by chalcogenapyrylium dyes.

Authors:  S K Powers; D L Walstad; J T Brown; M Detty; P J Watkins
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

View more
  3 in total

1.  Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.

Authors:  L F Reis de Sá; F T Toledo; A C Gonçalves; B A Sousa; A A Dos Santos; P F Brasil; V A Duarte da Silva; A C Tessis; J A Ramos; M A Carvalho; E Lamping; A Ferreira-Pereira
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

2.  Development of Novel Intramolecular FRET-Based ABC Transporter Biosensors to Identify New Substrates and Modulators.

Authors:  Bremansu Osa-Andrews; Kee W Tan; Angelina Sampson; Surtaj H Iram
Journal:  Pharmaceutics       Date:  2018-10-13       Impact factor: 6.321

3.  Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4.

Authors:  David Hardy; Roslyn M Bill; Anass Jawhari; Alice J Rothnie
Journal:  SLAS Discov       Date:  2019-08-05       Impact factor: 3.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.